Mithril Capital Management — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Fractylfractyl.com in 𝕏NASDAQ: GUTSJan 2022

Fractyl develops therapies for obesity and type 2 diabetes, focusing on non-drug-based approaches rooted in understanding metabolic disease mechanisms.

BiotechHealthtechMedical DevicesLexington, US

HARITH RAJAGOPALAN(Executive Officer, Director)JAY CAPLAN(Executive Officer, Director)Harith Rajagopalan(Executive Officer, Director)inLISA DAVIDSON(Executive Officer)Ajay Royan(Director)Christopher Gabrieli(Director)

Board seatAjay Royan· per SEC Form D

Co-investorsBessemer Venture Partners Catalio Capital Management, LP Emergent Medical Partners, LLP Polaris Partners Veltro Argento

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.